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a  b  s  t  r  a  c  t
INTRODUCTION:  Invasion  of  the  portal  and  hepatic  veins  by  hepatocellular  carcinoma  (HCC)  is  common,
but  macroscopic  bile  duct  invasion  is  rare.  Once  a tumor  thrombus  completely  obstructs  the main  bile
duct,  it causes  obstructive  jaundice.  This  type  of  HCC,  known  as  icteric-type  HCC (IHCC),  has  a poor
prognosis.
PRESENTATION  OF  CASE:  A  72-year-old  woman  had  been  treated  for  chronic  hepatitis  C  since  1997.  In  2002,
percutaneous  ethanol  injection  therapy  was  performed  for HCC  in  segment  8.  HCC  recurrence  occurred
in  2004,  and  she  underwent  transarterial  embolization  (TAE)  and  radiofrequency  ablation  (RFA).  In 2006,
an  S8  segmentectomy  was  performed  for re-recurrence  of  HCC.  Three  years  after  surgery,  computed
tomography  (CT) revealed  a tumor  occupying  the right  anterior  intrahepatic  bile duct  and extending  into
its  right  main  branch.  With  a  preoperative  diagnosis  of  HCC  recurrence  in  the  bile duct,  we  performed
a  right  hepatectomy  and  thrombectomy.  Histological  examination  showed  moderately  to  poorly  differ-
entiated  HCC.  No  tumor  tissue  other  than  the  intrahepatic  bile  duct  tumor  was  detected  in the resected
liver  specimen.
DISCUSSION:  HCC  with  biliary  tumor  thrombus  is  associated  with  a poor  prognosis.  In  general,  IHCC  is
difﬁcult  to diagnose  and  treat in  the  early  stages.  A  characteristic  radiological  ﬁnding  for  this  type  of  IHCC
is  the  hypervascularity  of  the  tumor  thrombus.
CONCLUSION: To  the  best  of  our  knowledge,  this  is  a  rare  case  of  IHCC  recurrence  as a  tumor  thrombus
without  recurrence  in  the  resected  liver  specimen.
gical © 2012 Sur
. Introduction
Hepatocellular carcinoma (HCC) is known to invade the por-
al and hepatic veins, but intrabiliary invasion is rare. Lin et al.
eferred to this type of HCC as “icteric-type HCC” (IHCC).1 The ini-
ial symptom of IHCC is obstructive jaundice due to compression or
cclusion of the bile duct by the tumor. HCC with bile duct invasion
as been reported in another study, enabling identiﬁcation of the
haracteristics of this particular disease.2
Tumor thrombus in the bile duct is one of the main reasons for
bstructive jaundice, and its incidence varies from 0.53% to 9%.3,4
everal studies have reported HCC with no obvious intrahepatic
umor but with a tumor thrombus in the bile duct.3,5 This special
ype of HCC is difﬁcult to identify preoperatively because the char-
cteristic radiological ﬁndings are not well known. The prognosis
f HCC with a tumor thrombus is dismal, but it is better than that of
aundice caused by hepatic insufﬁciency. Identiﬁcation at an early
tage is important in a clinical setting. Here, we report a case of HCC
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with a tumor thrombus and provide imaging ﬁndings to facilitate
preoperative diagnosis.
2.  Presentation of case
A 72-year-old woman  was admitted to our hospital in April
2009. She had been treated for hepatitis C virus infection. In 2002,
percutaneous ethanol injection therapy was  performed for pri-
mary HCC in segment 8. In 2003, she underwent transarterial
embolization (TAE) for HCC recurrence. Radiofrequency ablation
(RFA) was  performed for HCC recurrence 1 year after TAE. Patho-
logical ﬁndings indicated that the surgical margin was  preserved.
The woman  refused to undergo surgery, although she knew that
surgical resection was the best treatment for HCC. She subse-
quently underwent an S8 segmentectomy for HCC  recurrence.
Histopathological examination showed moderate-to-poorly differ-
entiated HCC. In addition, no invasion into the portal vein or bile
duct was  observed. Thereafter, she had no sign of recurrence for 3
Open access under CC BY-NC-ND license.years. On admission to hospital in 2009, a mass was  detected in the
right lobe of her liver by routine US. Tumor markers were within the
normal range: carcinoembryonic antigen, 2.9 ng/ml (≤5.0 ng/ml);
carbohydrate antigen 19-9, 91 U/ml (<37 U/ml); -fetoprotein,
BY-NC-ND license.
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mig. 1. (a) CT showing a well-enhanced tumor with a clear margin in the right bile du
n  the early phase (arrow). (c) The tumor stain was  washed out in the portal phase 
.9 ng/ml (≤10.0 ng/ml); and protein induced by vitamin K absence
r antagonist-II (PIVKA-II), 13 mAU/ml (≤40.0 mAU/ml). Computed
omography (CT) revealed a tumor in the right anterior intrahepatic
ile duct; this tumor extended into the right main branch. How-
ver, no signiﬁcant lesions were observed in the liver (Fig. 1a).
T hepatic arteriography and arterial portography demonstrated
hat the tumor was enhanced in the early phase and washed
ut in the late phase (Fig. 1b and c); this is a typical radio-
ogical ﬁnding in HCC cases. Magnetic resonance imaging with
he hepatocyte-speciﬁc contrast agent gadolinium ethoxybenzyl
iethylenetriaminepentaacetic acid showed that the tumor was of
ow intensity in the hepatobiliary phase (Fig. 2). With a preopera-
ive differential diagnosis of recurrent HCC invading the bile duct or
ntraductal cholangiocellular carcinoma, we performed a right hep-
tectomy and thrombectomy. Intraoperative US showed that the
umor thrombus reached the top of the common bile duct. We ﬁrst
erformed hepatectomy and then made an incision anterior to the
ommon bile duct. The tumor thrombus was easily removed with-
ut bleeding (Fig. 3a). Residual tumor tissue was not detected in the
ommon bile duct or the left bile duct on cholangioscopy. The tumor
hrombus was 30 mm × 40 mm in size, without bleeding, and was
ot adhered to the bile duct (Fig. 3b). On histological examination,
he tumor thrombus showed poorly differentiated HCC (Fig. 4). No
bvious intrahepatic mass was detected in the resected liver speci-
en. The patient was discharged without any major complications
Fig. 2. Magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetri-
aminepentaacetic acid (Gd-EOB-MRI) revealed that the tumor in the intrahepatic
bile  duct had a low intensity in the hepatobiliary phase (arrow).
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cig. 3. (a) The tumor thrombus was easily removed without bleeding. (b) The tumor
hrombus was  30 mm ×40 mm in size and was not adhered to the bile duct.
6 days after surgery because some time was  required to iden-
ify a suitable hospital for her rehabilitation. The patient remained
isease free after 1 year of follow-up.
. Discussion
There are 2 theories for the origin of a tumor thrombus in the
ile duct. (1) It originates in the ectopic liver tissue of the bile
uct.6 An ectopic liver, which is an accessory lobe, is often inci-
entally found near the gallbladder, hepatic ligaments, omentum,
7,8etroperitoneum, and thorax. (2) In most cases, the tumor throm-
us in the bile duct is derived from a HCC lesion in the liver. Once
he thrombus completely obstructs the main bile duct, it causes
bstructive jaundice. Lin et al. referred to this type of HCC as IHCC.1
ig. 4. Histopathological examination showed poorly differentiated hepatocellular
arcinoma  (HCC) (hematoxylin and eosin staining, 200×).PEN  ACCESS
ery Case Reports 3 (2012) 275– 278 277
HCC invades biliary systems through 1 of the following 3 mech-
anisms: (1) the tumor may  grow continuously in a distal fashion,
ﬁlling the entire extrahepatic biliary system with a solid cast of
tumor; (2) a fragment of necrotic tumor may  separate from the
proximal intraductal growth, migrating to the distal common bile
duct and causing obstruction; or (3) hemorrhage from the tumor
may partially or completely ﬁll the biliary tree with blood clots.9 In
our patient, no tumor tissues were identiﬁed in the resected liver
on histological examination despite careful sectioning and exam-
ination. The tumor thrombus showed poorly differentiated HCC.
Cellular differentiation in sections of the thrombus was similar to
that in the HCC that had been surgically removed 3 years previ-
ously. Therefore, the HCC in this patient was  believed to be formed
by slow growth of a residual tumor fragment in the bile duct.
Regardless  of remarkable advances in imaging modalities, it
remains difﬁcult to obtain a preoperative diagnosis for IHCC. US
and CT often misdiagnose these lesions as a “bile duct stone” or as
cholangiocarcinoma. Magnetic resonance cholangiography (MRCP)
is a noninvasive modality that has been shown to be superior to
endoscopic retrograde cholangiopancreatography (ERCP) in detect-
ing the presence of biliary obstruction. Dilation of the biliary system
and a primary liver tumor can be observed on MRCP. Tamada et al.
reported that intraductal US (IDUS) can be used to distinguish
between tumor thrombi caused by HCC and the polypoid type of
cholangiocarcinoma.10 However, ERCP and IDUS are more inva-
sive and require more specialized equipment than does MRCP. The
characteristic ﬁnding of tumor thrombi is an early enhancement
pattern on dual-phase contrast-enhanced CT; this is important in
differentiating cholangiocarcinoma.
The  ideal treatment for a patient with obstructive jaundice sec-
ondary to HCC is complete extirpation of the tumor by hepatic
resection. If tumor involvement is observed in the extrahepatic
ducts, the ducts can be resected en bloc along with the liver tumor.
If the ducts show tumor involvement, as with free ﬂoating-tumor
fragments that cause biliary obstruction, the tumor fragments can
be removed. This can then be followed by liver resection with-
out biliary-enteric anastomosis.11 In most cases, a tumor growing
within the bile duct does not adhere tightly to the duct wall; it usu-
ally adheres to the mucosa of the duct, but not the submucosal layer.
Such a tumor thrombus can be easily removed from the bile duct
during surgery. This is important from a surgical viewpoint because
even if the tumor thrombus in the bile duct protrudes into the con-
tralateral side of the tumor-bearing lobe, it can usually be removed
from the bile duct.12,13 Some authors have concluded that tumor
thrombectomy through a choledochotomy is contraindicated for
the treatment of a tumor thrombus because it might cause peri-
toneal dissemination.14,15 However, most surgeons believe that the
best treatment for tumor thrombus is liver resection and thrombec-
tomy, which result in a much better survival rate compared with
that after no resection.3,5 Therefore, to improve survival, if the
patient’s general condition and liver function are suitable, it is sug-
gested that major liver resection with thrombectomy should be
performed.
Ueda et al. reported a successful case in which the patient pre-
sented with a tumor thrombus 57 months after hepatectomy and
thrombectomy.2 These patients underwent a thrombectomy but
not reconstruction of the biliary tract. The blood supply to the
thrombus should be noted, and care should be taken to avoid mas-
sive bleeding during thrombectomy.2,16 Active hemorrhage during
thrombectomy can be controlled by suturing, electrocauterization,
compression, Pringle’s maneuver, and hepatic arterial ligation are
a few alternative means of achieving hemostasis.3The prognosis is poorer in such cases than in other types of
HCC.12 Most patients already have advanced-stage HCC at the time
of diagnosis, and curative resection is impossible. However, hepatic
resection is the only treatment that can prolong survival. Tumors in
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uch cases must be detected at an early stage, even in asymptomatic
arriers of viral hepatitis, by abdominal US. Tumor markers such as
FP and PIVKA-II should also be assessed.17
. Conclusion
We  presented a case of intrahepatic bile duct recurrence of
CC without a detectable tumor in the liver. Such cases have been
eported to have a poor prognosis in general, and surgical inter-
ention is recommended for cases similar to ours.18 However, if
he tumor is small and can be completely removed, the prognosis
ay improve. Differentiation from cholangiocellular carcinoma is
elatively difﬁcult, especially in cases of HCC. From a histological
iewpoint, liver resection should be performed if the patient’s liver
unction is suitable. Although this procedure is rarely performed, it
ust be kept in mind. Patients with suspected HCC should be inves-
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